Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies.
biopsy
cribriform
intraductal carcinoma
prostate cancer
Journal
Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
revised:
08
03
2022
received:
06
10
2021
accepted:
31
03
2022
pubmed:
7
4
2022
medline:
24
5
2022
entrez:
6
4
2022
Statut:
ppublish
Résumé
Invasive cribriform and intraductal carcinoma (IDC) are associated with adverse outcome in prostate cancer patients, with the large cribriform pattern having the worst outcome in radical prostatectomies. Our objective was to determine the impact of the large and small cribriform patterns in prostate cancer biopsies. Pathological revision was carried out on biopsies of 1887 patients from the European Randomised Study of Screening for Prostate Cancer. The large cribriform pattern was defined as having at least twice the size of adjacent benign glands. The median follow-up time was 13.4 years. Hazard ratios for metastasis-free survival (MFS) and disease-specific survival (DSS) were calculated using Cox proportional hazards regression. Any cribriform pattern was found in 280 of 1887 men: 1.1% IDC in grade group (GG) 1, 18.2% in GG2, 57.1% in GG3, 55.4% in GG4 and 59.3% in GG5; the large cribriform pattern was present in 0, 0.5, 9.8, 18.1 and 17.3%, respectively. In multivariable analyses, small and large cribriform patterns were both (P < 0.005) associated with worse MFS [small: hazard ratio (HR) = 3.04, 95% confidence interval (CI) = 1.93-4.78; large: HR = 3.17, 95% CI = 1.68-5.99] and DSS (small: HR = 4.07, 95% CI = 2.51-6.62; large: HR = 4.13, 95% CI = 2.14-7.98). Patients with the large cribriform pattern did not have worse MFS (P = 0.77) or DSS (P = 0.96) than those with the small cribriform pattern. Both small and large cribriform patterns are associated with worse MFS and DSS in prostate cancer biopsies. Patients with the large cribriform pattern on biopsy have a similar adverse outcome as those with the small cribriform pattern.
Identifiants
pubmed: 35384019
doi: 10.1111/his.14658
pmc: PMC9321809
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1041-1049Informations de copyright
© 2022 The Authors. Histopathology published by John Wiley & Sons Ltd.
Références
Histopathology. 2020 Nov;77(5):742-748
pubmed: 32542746
Mod Pathol. 2015 Mar;28(3):457-64
pubmed: 25189638
World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
BJU Int. 2003 Dec;92 Suppl 2:117-22
pubmed: 14983969
Am J Surg Pathol. 2020 Aug;44(8):e87-e99
pubmed: 32459716
Arch Pathol Lab Med. 2013 May;137(5):610-7
pubmed: 23627451
Mod Pathol. 2006 Dec;19(12):1528-35
pubmed: 16980940
Am J Clin Pathol. 2011 Jul;136(1):98-107
pubmed: 21685037
Mod Pathol. 2019 Jan;32(1):139-146
pubmed: 30349027
Histopathology. 2019 Sep;75(3):338-345
pubmed: 31045262
J Urol. 2019 Jul;202(1):90-95
pubmed: 30810466
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
Eur Urol. 2018 Apr;73(4):572-582
pubmed: 29129398
Am J Surg Pathol. 2013 Dec;37(12):1855-61
pubmed: 24145642
N Engl J Med. 2009 Mar 26;360(13):1320-8
pubmed: 19297566
Mod Pathol. 2018 Jan;31(S1):S143-155
pubmed: 29297492
Prostate. 2020 May;80(8):653-659
pubmed: 32220141
Adv Anat Pathol. 2018 Jan;25(1):31-37
pubmed: 28820750
Am J Surg Pathol. 2021 Aug 1;45(8):1118-1126
pubmed: 33999555
Eur Urol. 2019 Dec;76(6):790-813
pubmed: 31587989
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493
pubmed: 32589068
Am J Cancer Res. 2021 Aug 15;11(8):3990-4001
pubmed: 34522463
Histopathology. 2016 Sep;69(3):441-9
pubmed: 27028587
Histopathology. 2020 Dec;77(6):850-861
pubmed: 32683729
Prostate. 2020 Feb;80(2):146-152
pubmed: 31737920
Mod Pathol. 2016 Jun;29(6):630-6
pubmed: 26939875
Eur J Cancer. 2014 Jun;50(9):1610-6
pubmed: 24703897
J Urol. 2020 Feb;203(2):311-319
pubmed: 31483693
Histopathology. 2019 Feb;74(3):474-482
pubmed: 30160779
Virchows Arch. 2016 Sep;469(3):313-9
pubmed: 27394432